A Deep Learning-Based Assessment Pipeline for Intraepithelial and Stromal Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Carcinoma.

Journal: The American journal of pathology
Published Date:

Abstract

Tumor-infiltrating lymphocytes (TILs) are associated with improved survival in patients with epithelial ovarian cancer. However, TIL evaluation has not been used in routine clinical practice because of reproducibility issues. The current study developed two convolutional neural network models to detect TILs and to determine their spatial location in whole slide images, and established a spatial assessment pipeline to objectively quantify intraepithelial and stromal TILs in patients with high-grade serous ovarian carcinoma. The predictions of the established models showed a significant positive correlation with the number of CD8 T cells and immune gene expressions. Patients with a higher density of intraepithelial TILs had a significantly prolonged overall survival and progression-free survival in multiple cohorts. On the basis of the density of intraepithelial and stromal TILs, patients were classified into three immunophenotypes: immune inflamed, excluded, and desert. The immune-desert subgroup showed the worst prognosis. Gene expression analysis showed that the immune-desert subgroup had lower immune cytolytic activity and T-cell-inflamed gene-expression profile scores, whereas the immune-excluded subgroup had higher expression of interferon-γ and programmed death 1 receptor signaling pathway. The established evaluation method provided detailed and comprehensive quantification of intraepithelial and stromal TILs throughout hematoxylin and eosin-stained slides. It has potential for clinical application for personalized treatment of patients with ovarian cancer.

Authors

  • Kohei Hamada
    Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Ryusuke Murakami
    Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan. Electronic address: ryusukem@kuhp.kyoto-u.ac.jp.
  • Akihiko Ueda
    Department of Gynecology and Obstetrics, Kyoto University, Kyoto 606-8507, Japan.
  • Yoko Kashima
    Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine, Osaka, Japan.
  • Chiho Miyagawa
    Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine, Osaka, Japan.
  • Mana Taki
    Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Koji Yamanoi
    Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Ken Yamaguchi
    Shizuoka Cancer Center, Shizuoka, Japan.
  • Junzo Hamanishi
    Department of Gynecology and Obstetrics, Kyoto University, Kyoto 606-8507, Japan.
  • Sachiko Minamiguchi
    Department of Diagnostic Pathology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Noriomi Matsumura
    Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine, Osaka, Japan.
  • Masaki Mandai
    Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyoku, Kyoto, 606-8507, Japan.